Is a complete TNYA research report available?

No complete published report is available for Tenaya Therapeutics, Inc. (TNYA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Tenaya Therapeutics, Inc. (TNYA)

NASDAQ: TNYA · USD

$0.40

-0.00 (-0.1%)· Recorded snapshot

Market cap	90M
Revenue (ttm)	1.3M
Net income (ttm)	-103.1M
EPS (ttm)	-$0.53
Shares out	224.2M
Volume	1,169,563
Beta	2.88

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.3M
Net income (ttm): -103.1M
EPS (ttm): -$0.53
Market cap: 90M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Giữ

Metric	Value
Amount currency	USD
CIK code	0001858848
Company name	Tenaya Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	87990A106
Earnings date	2026-11-09
Earnings time	bmo
Employees	70
Employees change	-27
Employees growth	-27.84%
Enterprise value	$15.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2016
Industry	Biotechnology
IPO date	2021-07-30
Is primary listing	Yes
Is SPAC	No
ISIN number	US87990A1060
Last 10-K release date	2026-03-11
Last earnings date	2026-08-05
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$90M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$0.40
Price currency	USD
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	TNYA
U.S. state	California
Website	https://www.tenayatherapeutics.com

Metric

Value

Amount currency

USD

CIK code

0001858848

Company name

Tenaya Therapeutics, Inc.

Country

United States

Country code

CUSIP number

87990A106

Earnings date

2026-11-09

Earnings time

bmo

Employees

Employees change

-27

Employees growth

-27.84%

Enterprise value

$15.8M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2016

Industry

Biotechnology

IPO date

2021-07-30

Is primary listing

Yes

Is SPAC

ISIN number

US87990A1060

Last 10-K release date

2026-03-11

Last earnings date

2026-08-05

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$90M

Market cap category

Micro-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$0.40

Price currency

USD

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-28

Symbol

TNYA

U.S. state

California

Website

https://www.tenayatherapeutics.com

Metric	Value
Earnings yield	-132.93%
EV/Sales	13.06x
FCF / EV yield	-301.54%
FCF yield	-57.43%
Forward EV/Sales	2.84x
Forward P/S	14.91x
P/B ratio	1.3x
P/S ratio	68.6x
Price / tangible book value	1.32x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-132.93%

EV/Sales

13.06x

FCF / EV yield

-301.54%

FCF yield

-57.43%

Forward EV/Sales

2.84x

Forward P/S

14.91x

P/B ratio

1.3x

P/S ratio

68.6x

Price / tangible book value

1.32x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Gross margin	100%
Operating margin	-6,192.96%
Pretax margin	-7,723.97%
Profit per employee	$-1.5M
Revenue per employee	$19,071
ROA	-47.91%
ROA (5Y)	-35.25%
ROCE	-110.95%
ROE	-121.86%
ROE (5Y)	-65.31%
ROIC	-55.74%
SBC / revenue	717.3%

Metric

Value

Gross margin

100%

Operating margin

-6,192.96%

Pretax margin

-7,723.97%

Profit per employee

$-1.5M

Revenue per employee

$19,071

ROA

-47.91%

ROA (5Y)

-35.25%

ROCE

-110.95%

ROE

-121.86%

ROE (5Y)

-65.31%

ROIC

-55.74%

SBC / revenue

717.3%

Metric	Value
EPS growth years	5
Net income growth years	2
Revenue growth (QoQ)	393.33%
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth (QoQ)

393.33%

Revenue growth years

Metric	Value
Capital expenditures	$-263,000
Depreciation and amortization	$7.2M
EBIT	$-82.7M
EBITDA	$-75.5M
EPS	$-0.53
FCF per share	$-0.23
Financing cash flow	$59.1M
Free cash flow	$-52.6M
Free cash flow minus SBC	$-62.2M
Gross profit	$1.3M
Investing cash flow	$8.6M
Net cash flow	$15.4M
Net income	$-103.1M
Operating cash flow minus SBC	$-61.9M
Operating income	$-82.7M
Revenue	$1.3M
Stock-based compensation	$9.6M

Metric

Value

Capital expenditures

$-263,000

Depreciation and amortization

$7.2M

EBIT

$-82.7M

EBITDA

$-75.5M

EPS

$-0.53

FCF per share

$-0.23

Financing cash flow

$59.1M

Free cash flow

$-52.6M

Free cash flow minus SBC

$-62.2M

Gross profit

$1.3M

Investing cash flow

$8.6M

Net cash flow

$15.4M

Net income

$-103.1M

Operating cash flow minus SBC

$-61.9M

Operating income

$-82.7M

Revenue

$1.3M

Stock-based compensation

$9.6M

Metric	Value
Altman Z-Score	-7.55
Book value per share	$0.31
Debt / equity	0.06
Long-term assets	$7.5M
Long-term liabilities	$5.1M
Net cash (debt)	$74.1M
Net cash / market cap	80.96%
Net cash growth	24.69%
Net debt / equity	-1.07
Piotroski F-Score	1
Property, plant and equipment	$5.5M
Shareholders' equity	$69.4M
Tangible book value	$69.4M
Tangible book value per share	$0.31
Total assets	$93.5M
Total cash	$78.1M
Total debt	$3.9M
Total liabilities	$24.1M
WACC	19.24%

Metric

Value

Altman Z-Score

-7.55

Book value per share

$0.31

Debt / equity

0.06

Long-term assets

$7.5M

Long-term liabilities

$5.1M

Net cash (debt)

$74.1M

Net cash / market cap

80.96%

Net cash growth

24.69%

Net debt / equity

-1.07

Piotroski F-Score

Property, plant and equipment

$5.5M

Shareholders' equity

$69.4M

Tangible book value

$69.4M

Tangible book value per share

$0.31

Total assets

$93.5M

Total cash

$78.1M

Total debt

$3.9M

Total liabilities

$24.1M

WACC

19.24%

Metric	Value
Asset turnover	0.01
Current assets	$86M
Current liabilities	$19M
Current ratio	4.52
Net working capital	$-8.2M
Quick ratio	4.12
Working capital	$67M
Working capital turnover	0.02

Metric

Value

Asset turnover

0.01

Current assets

$86M

Current liabilities

$19M

Current ratio

4.52

Net working capital

$-8.2M

Quick ratio

4.12

Working capital

$67M

Working capital turnover

0.02

Metric	Value
Buyback yield / dilution	-73.58%
Dividend yield	0%
Shareholder yield	-73.58%

Metric

Value

Buyback yield / dilution

-73.58%

Dividend yield

Shareholder yield

-73.58%

Metric	Value
150-day SMA	$0.71
1D price change	-0.05%
1M price change	-33.09%
1M total return	-33.09%
1W price change	-0.51%
1W total return	-0.51%
1Y price change	-75.43%
1Y return CAGR	-75.45%
1Y total return	-75.43%
20-day SMA	$0.47
200-day SMA	$0.71
3M price change	-47%
3M total return	-47%
3Y price change	-76.82%
3Y return CAGR	-38.57%
3Y total return	-76.82%
50-day SMA	$0.59
50-day SMA vs 200-day SMA	50under200
52-week high	$1.65
52-week high date	2025-10-28
52-week low	$0.36
52-week low date	2026-10-14
5Y price change	-98.16%
5Y return CAGR	-55.04%
5Y total return	-98.16%
6M price change	-41.73%
6M total return	-41.73%
All-time high	$32.00
All-time high date	2021-11-08
All-time low	$0.36
All-time low date	2025-05-13
Average true range (ATR)	$0.04
Average volume	4M
Beta (1Y)	2.94
Beta (2Y)	3.02
Beta (5Y)	2.88
Change from 52-week high	-75.68%
Change from 52-week low	11.41%
Change from all-time high	-98.73%
Change from all-time low	13.31%
Change from open	-1.23%
Day's gap	1.2%
Dollar volume	$469,229
High price	$0.41
Low price	$0.40
Monthly RSI	37.37
Open price	$0.41
Position in 52-week range	0%
Premarket change	2.12%
Premarket close	$0.40
Premarket price	$0.41
Premarket volume	22.3K
Previous close	$0.40
Price vs 150-day SMA	-42.16%
Price vs 20-day SMA	-12.64%
Price vs 200-day SMA	-42.89%
Price vs 50-day SMA	-30.55%
Relative volume	0.3
Return from IPO open	-97.91%
Return from IPO price	-97.28%
RSI	33.27
Sharpe ratio	-0.93
Sharpe ratio (3Y)	0.08
Sharpe ratio (5Y)	-0.23
Sortino ratio	-1.26
Sortino ratio (3Y)	0.17
Sortino ratio (5Y)	-0.27
Volume	1.2M
Weekly RSI	34.17
YTD price change	-42.67%
YTD total return	-42.67%

Metric

Value

150-day SMA

$0.71

1D price change

-0.05%

1M price change

-33.09%

1M total return

-33.09%

1W price change

-0.51%

1W total return

-0.51%

1Y price change

-75.43%

1Y return CAGR

-75.45%

1Y total return

-75.43%

20-day SMA

$0.47

200-day SMA

$0.71

3M price change

-47%

3M total return

-47%

3Y price change

-76.82%

3Y return CAGR

-38.57%

3Y total return

-76.82%

50-day SMA

$0.59

50-day SMA vs 200-day SMA

50under200

52-week high

$1.65

52-week high date

2025-10-28

52-week low

$0.36

52-week low date

2026-10-14

5Y price change

-98.16%

5Y return CAGR

-55.04%

5Y total return

-98.16%

6M price change

-41.73%

6M total return

-41.73%

All-time high

$32.00

All-time high date

2021-11-08

All-time low

$0.36

All-time low date

2025-05-13

Average true range (ATR)

$0.04

Average volume

Beta (1Y)

2.94

Beta (2Y)

3.02

Beta (5Y)

2.88

Change from 52-week high

-75.68%

Change from 52-week low

11.41%

Change from all-time high

-98.73%

Change from all-time low

13.31%

Change from open

-1.23%

Day's gap

1.2%

Dollar volume

$469,229

High price

$0.41

Low price

$0.40

Monthly RSI

37.37

Open price

$0.41

Position in 52-week range

Premarket change

2.12%

Premarket close

$0.40

Premarket price

$0.41

Premarket volume

22.3K

Previous close

$0.40

Price vs 150-day SMA

-42.16%

Price vs 20-day SMA

-12.64%

Price vs 200-day SMA

-42.89%

Price vs 50-day SMA

-30.55%

Relative volume

0.3

Return from IPO open

-97.91%

Return from IPO price

-97.28%

RSI

33.27

Sharpe ratio

-0.93

Sharpe ratio (3Y)

0.08

Sharpe ratio (5Y)

-0.23

Sortino ratio

-1.26

Sortino ratio (3Y)

0.17

Sortino ratio (5Y)

-0.27

Volume

1.2M

Weekly RSI

34.17

YTD price change

-42.67%

YTD total return

-42.67%

Metric	Value
Float	211.7M
Float percentage	94.42%
Shares change (QoQ)	0.32%
Shares change (YoY)	73.58%
Shares held by insiders	0.41%
Shares held by institutions	21.21%
Shares outstanding	224.2M
Short % of float	10.83%
Short % of shares	10.22%
Short ratio	9.6 days

Metric

Value

Float

211.7M

Float percentage

94.42%

Shares change (QoQ)

0.32%

Shares change (YoY)

73.58%

Shares held by insiders

0.41%

Shares held by institutions

21.21%

Shares outstanding

224.2M

Short % of float

10.83%

Short % of shares

10.22%

Short ratio

9.6 days

Tenaya Therapeutics, Inc. (TNYA)

Price

Financial snapshot

Fair-value bridge

Latest news · TNYA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TNYA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TNYA

Frequently asked questions